LeafLine Labs Raises Another $2.5M

One of Minnesota’s two medical cannabis producers has raised another $2.5 million, according to a filing with the U.S. Securities and Exchange Commission.

The raise, by LeafLine Labs, comes on top of $12.4 million the company landed late last year. To date, LeafLine has raised $14.9 million – just $176,000 short of its goal.

The recent round of funding signals that investors are still interested in Minnesota’s medical marijuana market, despite the slow start to the state’s industry due…